Tergooi Ziekenhuizen

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Gastric and oesophageal cancer1 trial
• Lung cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1 trial
• The Netherlands Cancer Institute1 trial
• Zai Lab (Shanghai) Co., Ltd.1 trial

Running trials

• Recruiting

  A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

  NCT07218146· Phase 3· Zai Lab (Shanghai) Co., Ltd.· Source

• Recruiting

  OPTImaL:Optimisation of Treatment for Patients With Low Stage Triple-negative Breast Cancer With High Stromal Tumor-infiltrating Lymphocytes

  NCT06476119· The Netherlands Cancer Institute· Source

  Contact: A Willemsen, MD

• Active, not recruiting

  Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer

  NCT03764553· Phase 2· Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting
• Triple-negative breast cancer1 recruiting